Given the rising prevalence of cognitive impairment in COPD, researchers have called for increased efforts to identify risk factors and intervene earlier.

Long-acting bronchodilators may be combined with inhaled glucocorticosteroids, but the current GOLD guidelines call for minimizing the use of inhaled corticosteroids in COPD treatment. Doctors may ...